Renaissance Technologies - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 66 filers reported holding SOLENO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$102,000
+85.5%
550,131
+121.6%
0.00%
Q1 2022$55,000
+120.0%
248,200
+309.6%
0.00%
Q4 2021$25,000
+150.0%
60,600
+482.7%
0.00%
Q3 2021$10,000
-97.7%
10,400
-97.2%
0.00%
-100.0%
Q2 2021$427,000
+33.4%
374,185
+159.4%
0.00%
Q2 2020$320,000
+15.5%
144,259
+23.9%
0.00%
Q1 2020$277,000
-27.9%
116,461
-10.9%
0.00%
Q4 2019$384,000
+63.4%
130,761
-16.4%
0.00%
Q3 2019$235,000
-41.2%
156,372
+9.4%
0.00%
Q2 2019$400,000
+205.3%
142,905
+124.6%
0.00%
Q1 2019$131,00063,6230.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders